US Patent Issued to FIDIA FARMACEUTICI on Nov. 11 for "Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer" (Italian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,649, issued on Nov. 11, was assigned to FIDIA FARMACEUTICI S.p.A. (Abano Terme, Italy).

"Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer" was invented by Giorgio Mosconi (Abano Terme, Italy), Daniela Jabes (Abano Terme, Italy) and Carlo Pizzocaro (Abano Terme, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition is described, essentially consisting of the paclitaxel prodrug associated with pharmacologically acceptable diluents/excipients, for use in the treatment of non-muscle invasive bladder cancer (NMIBC) by means of intravesical instillations according to a single weekly do...